134 related articles for article (PubMed ID: 38728430)
1. The biological and clinical impact of deletions before and after large chromosomal gains in multiple myeloma.
Cirrincione AM; Poos AM; Ziccheddu B; Kaddoura M; Baertsch MA; Maclachlan KH; Chojnacka M; Diamond BT; John L; Reichert P; Huhn S; Blaney P; Gagler DC; Rippe K; Zhang Y; Dogan A; Lesokhin AM; Davies FE; Goldschmidt H; Fenk R; Weisel KC; Mai EK; Korde N; Morgan GJ; Usmani SZ; Landgren O; Raab MS; Weinhold N; Maura F
Blood; 2024 May; ():. PubMed ID: 38728430
[TBL] [Abstract][Full Text] [Related]
2. Impact of rare structural variant events in newly diagnosed multiple myeloma.
Chojnacka M; Diamond B; Ziccheddu B; Rustad E; Maclachlan K; Papadimitriou M; Boyle EM; Blaney P; Usmani S; Morgan G; Landgren O; Maura F
bioRxiv; 2023 Jan; ():. PubMed ID: 36711679
[TBL] [Abstract][Full Text] [Related]
3. Detection of chromosome 13q deletions and IgH translocations in patients with multiple myeloma by FISH: comparison with karyotype analysis.
Chang H; Li D; Zhuang L; Nie E; Bouman D; Stewart AK; Chun K
Leuk Lymphoma; 2004 May; 45(5):965-9. PubMed ID: 15291356
[TBL] [Abstract][Full Text] [Related]
4. Both IGH translocations and chromosome 13q deletions are early events in monoclonal gammopathy of undetermined significance and do not evolve during transition to multiple myeloma.
Kaufmann H; Ackermann J; Baldia C; Nösslinger T; Wieser R; Seidl S; Sagaster V; Gisslinger H; Jäger U; Pfeilstöcker M; Zielinski C; Drach J
Leukemia; 2004 Nov; 18(11):1879-82. PubMed ID: 15385925
[TBL] [Abstract][Full Text] [Related]
5. Impact of Rare Structural Variant Events in Newly Diagnosed Multiple Myeloma.
Chojnacka M; Diamond B; Ziccheddu B; Rustad E; Maclachlan K; Papadimitriou M; Boyle EM; Blaney P; Usmani S; Morgan G; Landgren O; Maura F
Clin Cancer Res; 2024 Feb; 30(3):575-585. PubMed ID: 37939148
[TBL] [Abstract][Full Text] [Related]
6. Newly diagnosed multiple myeloma patients carrying monoallelic deletion of the whole locus of immunoglobulin heavy chain gene have a better prognosis compared to those with t(4;14) and t(14;16).
Duek A; Trakhtenbrot L; Amariglio N; Benyamini N; Zilbershats I; Ganzel C; Shevetz O; Leiba R; Rozic G; Nagler A; Leiba M
Genes Chromosomes Cancer; 2019 Aug; 58(8):516-520. PubMed ID: 30675954
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors for hyperdiploid-myeloma: effects of chromosome 13 deletions and IgH translocations.
Chng WJ; Santana-Dávila R; Van Wier SA; Ahmann GJ; Jalal SM; Bergsagel PL; Chesi M; Trendle MC; Jacobus S; Blood E; Oken MM; Henderson K; Kyle RA; Gertz MA; Lacy MQ; Dispenzieri A; Greipp PR; Fonseca R
Leukemia; 2006 May; 20(5):807-13. PubMed ID: 16511510
[TBL] [Abstract][Full Text] [Related]
8. Deletions and amplifications of the IGH variable and constant regions:a novel prognostic parameter in patients with multiple myeloma.
Rabani H; Ziv M; Lavi N; Aviv A; Suriu C; Shalata A; Haddid Y; Tadmor T
Leuk Res; 2020 Dec; 99():106476. PubMed ID: 33171301
[TBL] [Abstract][Full Text] [Related]
9. Immunoglobulin heavy chain locus chromosomal translocations in B-cell precursor acute lymphoblastic leukemia: rare clinical curios or potent genetic drivers?
Dyer MJ; Akasaka T; Capasso M; Dusanjh P; Lee YF; Karran EL; Nagel I; Vater I; Cario G; Siebert R
Blood; 2010 Feb; 115(8):1490-9. PubMed ID: 20042721
[TBL] [Abstract][Full Text] [Related]
10. Additional-structural-chromosomal aberrations are associated with inferior clinical outcome in patients with hyperdiploid multiple myeloma: a single-institution experience.
Carballo-Zarate AA; Medeiros LJ; Fang L; Shah JJ; Weber DM; Thomas SK; Manasanch EE; Hao S; Shen Q; Orlowski RZ; Lin P; Lu X
Mod Pathol; 2017 Jun; 30(6):843-853. PubMed ID: 28281554
[TBL] [Abstract][Full Text] [Related]
11. Genomic analysis of multiple myeloma using targeted capture sequencing in the Japanese cohort.
Kanamori T; Sanada M; Ri M; Ueno H; Nishijima D; Yasuda T; Tachita T; Narita T; Kusumoto S; Inagaki A; Ishihara R; Murakami Y; Kobayashi N; Shiozawa Y; Yoshida K; Nakagawa MM; Nannya Y; Shiraishi Y; Chiba K; Tanaka H; Miyano S; Horibe K; Handa H; Ogawa S; Iida S
Br J Haematol; 2020 Dec; 191(5):755-763. PubMed ID: 32386081
[TBL] [Abstract][Full Text] [Related]
12. Distinguishing primary and secondary translocations in multiple myeloma.
Gabrea A; Leif Bergsagel P; Michael Kuehl W
DNA Repair (Amst); 2006 Sep; 5(9-10):1225-33. PubMed ID: 16829212
[TBL] [Abstract][Full Text] [Related]
13. Functional Impact of Genomic Complexity on the Transcriptome of Multiple Myeloma.
Ziccheddu B; Da Vià MC; Lionetti M; Maeda A; Morlupi S; Dugo M; Todoerti K; Oliva S; D'Agostino M; Corradini P; Landgren O; Iorio F; Pettine L; Pompa A; Manzoni M; Baldini L; Neri A; Maura F; Bolli N
Clin Cancer Res; 2021 Dec; 27(23):6479-6490. PubMed ID: 34526359
[TBL] [Abstract][Full Text] [Related]
14. Whole Exome Sequencing in Multiple Myeloma to Identify Somatic Single Nucleotide Variants and Key Translocations Involving Immunoglobulin Loci and MYC.
Walker BA
Methods Mol Biol; 2018; 1792():71-95. PubMed ID: 29797253
[TBL] [Abstract][Full Text] [Related]
15. The recurrent IgH translocations are highly associated with nonhyperdiploid variant multiple myeloma.
Fonseca R; Debes-Marun CS; Picken EB; Dewald GW; Bryant SC; Winkler JM; Blood E; Oken MM; Santana-Dávila R; González-Paz N; Kyle RA; Gertz MA; Dispenzieri A; Lacy MQ; Greipp PR
Blood; 2003 Oct; 102(7):2562-7. PubMed ID: 12805059
[TBL] [Abstract][Full Text] [Related]
16. A potential role for centrosomal deregulation within IgH translocation-positive myeloma.
Maxwell CA; Pilarski LM
Med Hypotheses; 2005; 65(5):915-21. PubMed ID: 16023302
[TBL] [Abstract][Full Text] [Related]
17. Translocations of 14q32 and deletions of 13q14 are common chromosomal abnormalities in systemic amyloidosis.
Harrison CJ; Mazzullo H; Ross FM; Cheung KL; Gerrard G; Harewood L; Mehta A; Lachmann HJ; Hawkins PN; Orchard KH
Br J Haematol; 2002 May; 117(2):427-35. PubMed ID: 11972529
[TBL] [Abstract][Full Text] [Related]
18. Chromosome aberrations in a series of 120 multiple myeloma cases with abnormal karyotypes.
Mohamed AN; Bentley G; Bonnett ML; Zonder J; Al-Katib A
Am J Hematol; 2007 Dec; 82(12):1080-7. PubMed ID: 17654686
[TBL] [Abstract][Full Text] [Related]
19. In multiple myeloma, 14q32 translocations are nonrandom chromosomal fusions driving high expression levels of the respective partner genes.
Tian E; Sawyer JR; Heuck CJ; Zhang Q; van Rhee F; Barlogie B; Epstein J
Genes Chromosomes Cancer; 2014 Jul; 53(7):549-57. PubMed ID: 24638926
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of specific miRNAs in hyperdiploid multiple myeloma mimics the oncogenic effect of IgH translocations occurring in the non-hyperdiploid subtype.
Rio-Machin A; Ferreira BI; Henry T; Gómez-López G; Agirre X; Alvarez S; Rodriguez-Perales S; Prosper F; Calasanz MJ; Martínez J; Fonseca R; Cigudosa JC
Leukemia; 2013 Apr; 27(4):925-31. PubMed ID: 23174883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
